Related references
Note: Only part of the references are listed.The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis
Nipat Chuleerarux et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Invasive mold infections in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
Sheng-Hsuan Chien et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2019)
Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy
Sung-Yeon Cho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia
Cheng-Hsien Lin et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
CMV Prevention and Treatment in Transplantation: What's New in 2019
Anat Stern et al.
CURRENT INFECTIOUS DISEASE REPORTS (2019)
New Developments in the Management of Cytomegalovirus Infection After Transplantation
Atibordee Meesing et al.
DRUGS (2018)
Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study
Sabine Kuster et al.
TRANSPLANT INFECTIOUS DISEASE (2018)
Invasive fungal disease and cytomegalovirus infection: is there an association?
Michelle K. Yong et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials
Per Ljungman et al.
CLINICAL INFECTIOUS DISEASES (2017)
Cytomegalovirus Infection and Treatment in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from a Single Institution in an Endemic Area
Hsin-Chen Lin et al.
TURKISH JOURNAL OF HEMATOLOGY (2017)
Cytomegalovirus Reactivation Is Associated with Increased Risk of Late-Onset Invasive Fungal Disease after Allogeneic Hematopoietic Stern Cell Transplantation: A Multicenter Study in the Current Era of Viral Load Monitoring
Michelle K. Yong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: Why the quest for meaningful prophylaxis still matters
Shawna T. Chan et al.
BLOOD REVIEWS (2017)
Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients
Silvia Park et al.
JOURNAL OF INFECTION (2016)
Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation
Yao-Chung Liu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
Nicole Harrison et al.
BMC INFECTIOUS DISEASES (2015)
Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years
Ji-min Shi et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients
A. Atalla et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review
Hugo Sousa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italian Trapianto Midollo Osseo (GITMO)
Corrado Girmenia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
An Investigation on the Relationship Between the Occurrence of CMV DNAemia and the Development of Invasive Aspergillosis in the Allogeneic Stem Cell Transplantation Setting
Estela Gimenez et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
Risk Factors for Invasive Fungal Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
Aazim K. Omer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus
Yi-Chang Liu et al.
ANNALS OF HEMATOLOGY (2012)
Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant
Xiaojun Huang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection
Michael J. Cannon et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT
R. Martino et al.
BONE MARROW TRANSPLANTATION (2009)
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients
M. Mikulska et al.
BONE MARROW TRANSPLANTATION (2009)
Prophylaxis and Treatment of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Results of a Consensus Process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Corrado Girmenia et al.
CLINICAL INFECTIOUS DISEASES (2009)
Human Cytomegalovirus Paralyzes Macrophage Motility through Down-Regulation of Chemokine Receptors, Reorganization of the Cytoskeleton, and Release of Macrophage Migration Inhibitory Factor
Giada Frascaroli et al.
JOURNAL OF IMMUNOLOGY (2009)
Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: Biological risk factors for infection according to time after transplantation
Carol Garcia-Vidal et al.
CLINICAL INFECTIOUS DISEASES (2008)
High perinatal seroprevalence of cytomegalovirus in northern Taiwan
Mei-Huei Chen et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2008)
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation
Pierre-Yves Bochud et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Relevance of Toll-like receptor-4 polymorphisms in renal transplantation
D Ducloux et al.
KIDNEY INTERNATIONAL (2005)
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
E Jantunen et al.
BONE MARROW TRANSPLANTATION (2004)
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning
T Fukuda et al.
BLOOD (2003)
High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation
EA Hagen et al.
CLINICAL INFECTIOUS DISEASES (2003)
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study
C Junghanss et al.
BLOOD (2002)
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation:: incidence and risk factors in 395 patients
R Martino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
The impact of CMV on the respiratory burst of macrophages in response to Pneumocystis carinii
AL Laursen et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2001)
Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
